XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
RELATED PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
On March 8, 2021, the Company entered into an Equity Commitment and Investment Agreement with the PIPE Investor, pursuant to which 25,000 shares were purchased for $1,000 per share for an aggregate purchase price of $25.0 million on November 19, 2021. The Chairman of the Company's board of directors is an operating partner of Ampersand Capital Partners, an affiliate of the PIPE Investor.
In connection with the acquisition of Novitium, the Company entered into employment agreements with the two executives and founders of Novitium, Muthusamy Shanmugam and Chad Gassert. Both serve as executive officers of the Company and Mr. Shanmugam also serves on the Company’s board of directors. Mr. Shanmugam holds a minority interest in Scitus Pharma Services (“Scitus”), which provides clinical research services to Novitium; majority interest in SS Pharma LLC (“SS Pharma”), which acquires and supplies API to Novitium; majority interest in Esjay Pharma LLC (“Esjay”), which provided research and development and facilities consulting services; and a minority interest in Nuray Chemical Private Limited (“Nuray”), which manufactures and supplies API to Novitium. As of September 30, 2022, Esjay no longer provided research and development and facilities consulting services to Novitium or ANI. Mr. Gassert holds a minority interest in Scitus.
A summary of payments to related parties is presented below:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Scitus Pharma Services$1,322 $515 $3,227 $1,865 
SS Pharma LLC2,480 843 6,059 2,488 
Esjay Pharma LLC— — — 101 
Nuray Chemical Private Limited— 10 — 878 
$3,802 $1,368 $9,286 $5,332 
As of September 30, 2023, the outstanding balances due to Scitus and SS Pharma were $0.4 million and $0.8 million, respectively. There was no outstanding balance due to Nuray or Esjay at September 30, 2023.